258 related articles for article (PubMed ID: 26844773)
1. Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics.
Kalinowski DS; Stefani C; Toyokuni S; Ganz T; Anderson GJ; Subramaniam NV; Trinder D; Olynyk JK; Chua A; Jansson PJ; Sahni S; Lane DJ; Merlot AM; Kovacevic Z; Huang ML; Lee CS; Richardson DR
Biochim Biophys Acta; 2016 Apr; 1863(4):727-48. PubMed ID: 26844773
[TBL] [Abstract][Full Text] [Related]
2. Catalytic therapy of cancer by ascorbic acid involves redox cycling of exogenous/endogenous copper ions and generation of reactive oxygen species.
Hadi SM; Ullah MF; Shamim U; Bhatt SH; Azmi AS
Chemotherapy; 2010; 56(4):280-4. PubMed ID: 20714144
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes.
Lovejoy DB; Jansson PJ; Brunk UT; Wong J; Ponka P; Richardson DR
Cancer Res; 2011 Sep; 71(17):5871-80. PubMed ID: 21750178
[TBL] [Abstract][Full Text] [Related]
4. Exploiting Cancer Metal Metabolism using Anti-Cancer Metal- Binding Agents.
Merlot AM; Kalinowski DS; Kovacevic Z; Jansson PJ; Sahni S; Huang ML; Lane DJR; Lok H; Richardson DR
Curr Med Chem; 2019; 26(2):302-322. PubMed ID: 28685681
[TBL] [Abstract][Full Text] [Related]
5. Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics.
Park KC; Fouani L; Jansson PJ; Wooi D; Sahni S; Lane DJ; Palanimuthu D; Lok HC; Kovačević Z; Huang ML; Kalinowski DS; Richardson DR
Metallomics; 2016 Sep; 8(9):874-86. PubMed ID: 27334916
[TBL] [Abstract][Full Text] [Related]
6. Novel chelators for cancer treatment: where are we now?
Merlot AM; Kalinowski DS; Richardson DR
Antioxid Redox Signal; 2013 Mar; 18(8):973-1006. PubMed ID: 22424293
[TBL] [Abstract][Full Text] [Related]
7. Expanding horizons in iron chelation and the treatment of cancer: role of iron in the regulation of ER stress and the epithelial-mesenchymal transition.
Lane DJ; Mills TM; Shafie NH; Merlot AM; Saleh Moussa R; Kalinowski DS; Kovacevic Z; Richardson DR
Biochim Biophys Acta; 2014 Apr; 1845(2):166-81. PubMed ID: 24472573
[TBL] [Abstract][Full Text] [Related]
8. Redox cycling of endogenous copper by ferulic acid leads to cellular DNA breakage and consequent cell death: A putative cancer chemotherapy mechanism.
Sarwar T; Zafaryab M; Husain MA; Ishqi HM; Rehman SU; Rizvi MM; Tabish M
Toxicol Appl Pharmacol; 2015 Dec; 289(2):251-61. PubMed ID: 26415834
[TBL] [Abstract][Full Text] [Related]
9. Advances in metal-induced oxidative stress and human disease.
Jomova K; Valko M
Toxicology; 2011 May; 283(2-3):65-87. PubMed ID: 21414382
[TBL] [Abstract][Full Text] [Related]
10. Metals and metastasis: Exploiting the role of metals in cancer metastasis to develop novel anti-metastatic agents.
Fouani L; Menezes SV; Paulson M; Richardson DR; Kovacevic Z
Pharmacol Res; 2017 Jan; 115():275-287. PubMed ID: 27940016
[TBL] [Abstract][Full Text] [Related]
11. Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species.
Fatfat M; Merhi RA; Rahal O; Stoyanovsky DA; Zaki A; Haidar H; Kagan VE; Gali-Muhtasib H; Machaca K
BMC Cancer; 2014 Jul; 14():527. PubMed ID: 25047035
[TBL] [Abstract][Full Text] [Related]
12. The anticancer drug Dp44mT inhibits T-cell activation and CD25 through a copper-dependent mechanism.
Gundelach JH; Madhavan AA; Wettstein PJ; Bram RJ
FASEB J; 2013 Feb; 27(2):782-92. PubMed ID: 23134680
[TBL] [Abstract][Full Text] [Related]
13. Thiosemicarbazones: the new wave in cancer treatment.
Kalinowski DS; Quach P; Richardson DR
Future Med Chem; 2009 Sep; 1(6):1143-51. PubMed ID: 21425997
[TBL] [Abstract][Full Text] [Related]
14. Heavy-metal-induced reactive oxygen species: phytotoxicity and physicochemical changes in plants.
Shahid M; Pourrut B; Dumat C; Nadeem M; Aslam M; Pinelli E
Rev Environ Contam Toxicol; 2014; 232():1-44. PubMed ID: 24984833
[TBL] [Abstract][Full Text] [Related]
15. Methemoglobin formation by triapine, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and other anticancer thiosemicarbazones: identification of novel thiosemicarbazones and therapeutics that prevent this effect.
Quach P; Gutierrez E; Basha MT; Kalinowski DS; Sharpe PC; Lovejoy DB; Bernhardt PV; Jansson PJ; Richardson DR
Mol Pharmacol; 2012 Jul; 82(1):105-14. PubMed ID: 22508546
[TBL] [Abstract][Full Text] [Related]
16. Redox metals in Alzheimer's disease.
Todorich BM; Connor JR
Ann N Y Acad Sci; 2004 Mar; 1012():171-8. PubMed ID: 15105264
[TBL] [Abstract][Full Text] [Related]
17. Chelators controlling metal metabolism and toxicity pathways: applications in cancer prevention, diagnosis and treatment.
Kontoghiorghes GJ; Efstathiou A; Ioannou-Loucaides S; Kolnagou A
Hemoglobin; 2008; 32(1-2):217-27. PubMed ID: 18274999
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Metal Homeostasis for Cancer Therapy.
Yang Y; Fan H; Guo Z
Chempluschem; 2024 Jun; 89(6):e202300624. PubMed ID: 38315756
[TBL] [Abstract][Full Text] [Related]
19. Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity.
Jansson PJ; Sharpe PC; Bernhardt PV; Richardson DR
J Med Chem; 2010 Aug; 53(15):5759-69. PubMed ID: 20597487
[TBL] [Abstract][Full Text] [Related]
20. Experimental therapeutics: targeting the redox Achilles heel of cancer.
Cabello CM; Bair WB; Wondrak GT
Curr Opin Investig Drugs; 2007 Dec; 8(12):1022-37. PubMed ID: 18058573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
